Anita Wiseth Email

SVP, HR . Oncternal

Current Roles

Employees:
40
Revenue:
$4.5M
About
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression. The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers. Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.
Oncternal Address
12230 El Camino Real
San Diego, CA
United States
Oncternal Email

Past Companies

Oncternal TherapeuticsSenior Vice President, HR
Matheson ConsultingLife Sciences and High Tech HR Consultant
Halozyme Therapeutics, Inc.Vice President, HR

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.